Search patent PK data by peptide sequence
Measured in vivo half-lives from deep inside patents, each tied to the peptide's structure. Covering GLP-1, GIP, glucagon, and amylin.
Structured patent data
Start from a sequence, a target, or a patent. Every half-life is linked to the exact peptide tested.
Sequence
Trace a half-life to its exact chemistry
Full sequence, non-natural residues, albumin binder — the chemistry behind the number.
Database
Filter every study down to your criteria
Filter by target, species, route, and modality, then sort by half-life.
Patent detail
See a patent's half-lives and compounds
Each study shows its important metadata, such as dose, number of subjects, and more.
Patents publish first
A new peptide's structure and in vivo half-life usually appear first in a patent application, often years before a paper. Many never reach a journal. The data sits in scanned tables that no search engine reads.
Ahead of the literature
See a competitor's sequences and half-lives when their application publishes, not when the paper does.
Every competitor, side by side
Compare half-lives across companies, targets, and extension chemistries — data otherwise scattered across hundreds of patents.
Pricing
What's included
- Search by peptide sequence, with the full structure of every compound
- Half-life data for GLP-1, GIP, glucagon, and amylin peptides
- Filter by target, modality, species, route, and assignee
- Every study's dose, species, and route, per patent